GB0426393D0 - Materials and methods relating to modulators of spindle checkpoint kinases - Google Patents
Materials and methods relating to modulators of spindle checkpoint kinasesInfo
- Publication number
- GB0426393D0 GB0426393D0 GBGB0426393.5A GB0426393A GB0426393D0 GB 0426393 D0 GB0426393 D0 GB 0426393D0 GB 0426393 A GB0426393 A GB 0426393A GB 0426393 D0 GB0426393 D0 GB 0426393D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- modulators
- materials
- methods relating
- spindle checkpoint
- checkpoint kinases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 230000019130 spindle checkpoint Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0426393.5A GB0426393D0 (en) | 2004-12-01 | 2004-12-01 | Materials and methods relating to modulators of spindle checkpoint kinases |
| PCT/GB2005/004622 WO2006059121A2 (en) | 2004-12-01 | 2005-12-01 | Modulators of spindle checkpoint kinases and a taxol |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0426393.5A GB0426393D0 (en) | 2004-12-01 | 2004-12-01 | Materials and methods relating to modulators of spindle checkpoint kinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0426393D0 true GB0426393D0 (en) | 2005-01-05 |
Family
ID=34043885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0426393.5A Ceased GB0426393D0 (en) | 2004-12-01 | 2004-12-01 | Materials and methods relating to modulators of spindle checkpoint kinases |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0426393D0 (en) |
| WO (1) | WO2006059121A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2589918A1 (en) * | 2004-12-08 | 2006-06-15 | Dorre Grueneberg | Method for measuring resistance or sensitivity to docetaxel comprising detection of tacc3 |
| WO2008116161A2 (en) * | 2007-03-22 | 2008-09-25 | The General Hospital Corporation | Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states |
| TW201102081A (en) | 2009-05-11 | 2011-01-16 | Oncotherapy Science Inc | TTK peptides and vaccines including the same |
| CN116870167B (en) * | 2023-08-24 | 2024-11-08 | 四川大学 | A combined drug and drug composition for treating solid tumors |
-
2004
- 2004-12-01 GB GBGB0426393.5A patent/GB0426393D0/en not_active Ceased
-
2005
- 2005-12-01 WO PCT/GB2005/004622 patent/WO2006059121A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006059121A3 (en) | 2007-04-05 |
| WO2006059121A2 (en) | 2006-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL191139A0 (en) | Novel pyridopyrazines and their use as modulators of kinases | |
| IL181524A0 (en) | Heterocyclic compounds and methods of use | |
| IL180775A0 (en) | Modulators of alph7 nicotinic acetylcholine receptors and therapeutic uses thereof | |
| SI1984353T1 (en) | Aurora kinase modulators and method of use | |
| IL176958A0 (en) | Compounds and methods of use | |
| IL192812A0 (en) | Aurora kinase modulators and method of use | |
| IL185914A0 (en) | Pyrimidine compounds and methods of use | |
| ZA200900058B (en) | Superabrasive materials and methods of manufacture | |
| IL178593A (en) | Fcγriib-specific antibodies and methods of use thereof | |
| EP1751124A4 (en) | Raf modulators and methods of use | |
| IL213843A0 (en) | 4-aminotetracyclines and methods of use thereof | |
| ZA200805741B (en) | Anti-MN antibodies and methods of using same | |
| IL186970A0 (en) | Thiazole compounds and methods of use | |
| AU2006330807A8 (en) | Antagonists of HMBG1 and/or rage and methods of use thereof | |
| EP1874759A4 (en) | C-met modulators and methods of use | |
| EP1678168A4 (en) | P70s6 kinase modulators and method of use | |
| PL2099796T3 (en) | Aza-indolyl compounds and methods of use | |
| SI1906965T1 (en) | Azaindazole compounds and methods of use | |
| EP2021555A4 (en) | Structural element and methods of use thereof | |
| IL178161A0 (en) | Bonded thin-film structures for optical modulators and methods of manufacture | |
| ZA200707083B (en) | Isoquinoline compounds and methods of use thereof | |
| ZA200607582B (en) | Anti-parasitic compounds and methods of their use | |
| EP1871761A4 (en) | Spirocyclic heterocyclic derivatives and methods of their use | |
| GB0702729D0 (en) | Methods of extending the shelf life of and revitalizing lightweight beads for use in cement compositions | |
| GB2440843B (en) | Liquid sealant and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |